Stay updated with breaking news from Ohnson Johnson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The settlement would avert potential lawsuits alleging J&J hid any links between the talc in its powder and various cancers, the report said citing people familiar with the deal. J&J and representatives for state attorneys general are still working out the specific terms of the deal but have agreed on the total amount, Bloomberg News reported. J&J did not immediately respond to a Reuters request for comment.
Novartis is poised to prevail in the auction for Cytokinetics, ahead of other bidders that include AstraZeneca and Johnson & Johnson, according to the source. A deal could be announced as early as this week, the source said, helping Novartis gain access to Cytokinetics' experimental treatment, aficamten, for hypertrophic cardiomyopathy (HCM), an inherited chronic heart disease that can cause cardiac arrest.
Better sober living homes, mid-Cape detox center, basic needs fulfilled: a wish list for how Cape towns could spend $8.3M in opioid settlement.
A modest amount of money can go a long way when it's put to work in industry-leading, time-tested businesses with well-defined catalysts.
These companies need no introduction.